Recently approved by the US Food and Drug Administration (FDA) as the first oral GLP-1RA for treating T2DM, Sema has demonstrated cardiovascular benefits in clinical trials involving patients with T2DM 16
Expert Consultations: Hint Premium provides unlimited consultations with dietitians who can help tailor your diet and lifestyle to maximize the benefits of Rybelsus
Lilly's triple agonist retatrutide posts its strongest weight loss numbers yet, setting up a 2027 FDA filing Eli Lilly, this week, reported positive topline results from TRIUMPH-2 and TRIUMPH-3, two pivotal Phase 3 trials of retatrutide, a once-weekly injectable that activates receptors for GIP, GLP-1, and glucagon simultaneously a triple mechanism that no approved obesity therapy currently matches
Food & Function , 1
Its once-weekly injection makes it a more convenient choice for those with busy lifestyles
Among patients who switched from AOM tirzepatide to a different GLP-1, the majority transitioned to AOM semaglutide, aligning with its status as the CVS Caremark preferred therapy
